Loxoptic 5 Mg/Ml Ophthalmic Solution 5 mg/ml Ophthalmic Solution
PDF Leaflet Revision Date: 11 November 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of chronic open-angle glaucoma and elevated intraocular pressure.
Dosage (summary)
One drop in affected eye(s) twice daily.
Onset of Action / Duration
Onset: 30 mins, Duration: 12-24 hours
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy not established; caution in breastfeeding.
Key Drug Interactions
- Calcium channel blockers
- Beta blockers
- Anti-dysrhythmics
- Hypoglycaemic agents
Contraindications
- Hypersensitivity to betaxolol
- Cardiac shock
- Sinus bradycardia
- Reactive airway disease
- Damaged cornea
Common side effects
- Eye discomfort
- Headache
- Dry eyes
- Dizziness
Counselling Points
- Avoid contact lenses during use
- Monitor for signs of cardiac failure
- Use caution when driving or operating machinery
Serious warnings
- Risk of bronchospasm
- Caution in cardiac failure
- Potential for systemic effects
Important Disclaimer
The Loxoptic 5 Mg/Ml Ophthalmic Solution 5 mg/ml Ophthalmic Solution professional information leaflet below is the property of Gen-Eye and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
